🔎 Trials Near Me

Utama › Kanser Metastatik › Indiana › Indianapolis

Kajian klinikal Kanser Metastatik di Indianapolis, IN

19 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Indianapolis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Mengambil pesertaFasa 1
  • IU Simon Cancer Center, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06625775

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Mengambil pesertaFasa 3
  • Franciscan Health, Indianapolis
  • Franciscan Health Mooresville, Mooresville · 16 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Community Health Network, Inc, Indianapolis
  • Community Health Network, Inc., Indianapolis
  • Community Health Network, Inc., Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07222566

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Mengambil pesertaFasa 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Mengambil pesertaFasa 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Mengambil pesertaFasa 3
  • Indiana University Health University Hospital, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Mengambil pesertaFasa 1/2
  • Community Health Network, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

Mengambil pesertaFasa 1
  • Community Health Network MD Anderson Cancer Center - North, Indianapolis
Umur 18 hingga 99 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07403721

Prospective Validation of a Points Score System Predicting 30-day Survival

Mengambil pesertaKajian pemerhatian
  • Methodist Hospital, Indianapolis
  • IU Health West, Avon · 13 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT05100342

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • Community Cancer Center North, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Community Cancer Center North, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07602842

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Mengambil pesertaFasa 1
  • Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05614739

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Community Health Network, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Mengambil pesertaFasa 3
  • Research Site, Indianapolis
Umur 18 ke atas · Wanita · Dikemas kini 29 Jul 2026 · NCT07044336

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Mengambil pesertaFasa 3
  • Franciscan Health Indianapolis, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT06216301

A Study of LY4175408 in Participants With Advanced Cancer

Mengambil pesertaFasa 1
  • Community Health Network, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jun 2026 · NCT07046923

Evaluating Disparities in Precision Oncology

Mengambil pesertaKajian pemerhatian
  • Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jun 2026 · NCT06081517

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Mengambil pesertaFasa 2/3
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Umur 18 ke atas · Lelaki · Dikemas kini 8 Apr 2026 · NCT04787744

Kajian Kanser Metastatik di bandar lain

Kajian lain di Indianapolis

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.